Pharmaceutical Care Practice of Proton Pump Inhibitors and Its Interactions with Other Drugs

Abstract

Abstract: Objective To provide reference for clinical pharmacists to carry out drug-drug interactions based medication monitoring. Methods In clinical practice, clinical pharmacists often encounter drug-drug interaction instances of proton pump inhibitors (PPIs) with other drugs, the investigation in how to carry out clinical pharmacy care considering of medicine interactions as the main point helps to avoid reduced potency and adverse drug reactions due to medicine interactions. Results & Conclusion Only through participating in the clinical work, discovering potential drug-drug interactions and giving interventions on time, patient’s medication can be ensured safely. The clinical pharmacists must improve occupational sensitivity and find the right way to make full use of expertise and advantage.

Key words: clinical pharmacist, drug interaction, proton pump inhibitors

CLC Number:

R969.2

LI Hai-yan, HU Bin . Pharmaceutical Care Practice of Proton Pump Inhibitors and Its Interactions with Other Drugs [J]. Chinese Journal of Pharmacovigilance, 2016, 13(7): 429-432.

References

[1] 中国医院协会药事管理专业委员会.质子泵抑制剂临床应用的药学监护[M].1版，人民卫生出版社，2013 : 6，27-29.
[2] Ishizaki T,Horai Y. Review article：cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole [J]. Alimentary Pharmacology&Therapeutics,1999, 13 (S3) : 27-36.
[3] Lind T, Rydberg L, Kyleback A. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastrooesophageal reflux disease[J]. Alimentary Pharmacology & Therapeutics,2000, 14(7) : 861-867.
[4] Blume H, Donath F, Warnke A, et al. Pharmacokinetic drug interaction profiles of proton pump inhibitors[J]. Drug Safety, 2006, 29(9) : 769-784.
[5] 刘波, 姚鸿萍. 临床常用质子泵抑制剂的研究进展[J].西北药学杂志, 2014, 29(3) : 328-332.
[6] 周尔文, 寿军, 李光武, 等.综合性医院门诊处方中常见CYP3A4抑制剂和诱导剂的代谢性相互作用调查[J].中国医药指南, 2013, 11(19) : 489-491.
[7] 祝锡聪. 埃索美拉唑的临床应用与安全性[J].药物流行病学杂志, 2007, 16(4) : 215-217.
[8] 李旭梅,涂厉标.奥美拉唑的化学配伍禁忌及药物相互作用[J].中国临床药学杂志,2009, 18(5) : 320-322.
[9] 陈坚. 质子泵抑制剂的分类及药理学特性[J]. 上海医药, 2013, 34(21) : 3-7.
[10] 彭华, 程泽能. 细胞色素P450-3A4相关的药物相互作用[J]. 中国临床药理学杂志, 2001, 17(5) : 379-385.
[11] David W J, Clark, Johanna Strandell. Myopathy including polymyositis:a likely class adverse effect of proton pump inhibitors[J].European Journal of Clinical Pharmacology, 2006, 62(6) : 473-479.
[12] Vlase L,Neag M, Popa A, et al.Pharmacokinetic interaction between fluoxetine and omeprazole in healthy male volunteers:a prospective pilot study[J]. Current Therapeutic Research, 2010,71(6) : 360-368.
[13] F.Itagaki, M.Homma, K.Yuzawa,et al. Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation[J]. Transplantation Proceedings, 2002, 34(7) : 2777-2778.
[14] Calabresi L, Pazzucconi F, Ferrara S, et al. Pharmacokinetic interaction between omeprazole/pantoprazole and clarithromycin in healthy volunteers[J]. Pharmacological Reasearch, 2004, 49(5) :493-499.
[15] Pilsgaard H D, Bjerregaard S T,Rix H M , et al. The potential drug-drug interaction between proton pump inhibitors and warfarin[J]. Pharmacoepidemiology & Drug Safety, 2015, 24 : 1337–1340.
[16] Agewall S, Cattaneo M, Collet JP, et al. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy[J]. European Heart Journal, 2013, 34 : 1708–1713.
[17] Gilard M, Arnaud B, Cornily J C, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study[J]. Journal of the American College of Cardiology, 2008, 51(3) : 256-260.
[18] Zuern C S,Geisler T,Lutilsky N, et al. Effect of comedication with proton pump inhibitors(PPI) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy[J]. Thrombosis Research, 2010, 125 : e51-e54.
[19] Troger U，Stotzel B，Martens-Lobenhoffer J, et al. Severe myalgia from an interaction between treatments with pantoprazole and
methotrexate[J]. British Medical Journal, 2002, 324(7352) : 1 497.
[20] Yucel E, Sancar M,Yucel A. Adverse drug reactions due to drug- drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method[J]. Expert Opinion on Drug Safety, 2016, 15(2) : 223-236.
[21] Bouziana S D, Tziomalos K. Clinical relevance of clopidogrel-proton pump inhibitors interaction[J]. World Journal of Gastrointestinal Pharmacology and Therapeutics, 2015, 6(2) : 17-21.
[22] 魏春燕, 吴逢波. CYP450与药物相互作用[J].中国药业, 2014, 23(6) : 17-20.